Roger Tuen brings more than 20 years of international life science experience in commercial, business development and general management roles in listed companies. He has negotiated several licensing agreements with multinational and regional companies, and managed strategic alliances and partnerships throughout his career. He holds a MSc in Pharmacy from the University of Oslo and a MBA from the Norwegian School of Management and ESCP-EAP, France.

Dr. Svendsen brings extensive research experience in medical biochemistry, synthetic organic chemistry and medicinal chemistry, specializing in antibacterial peptides. Dr. Svendsen received his PhD from the University of Tromsø, and has been visiting scientist at several distinguished international institutions, including in the laboratory of Professor K.B. Sharpless (Nobel Laureate, Chemistry, 2001 and 2022) at Massachusetts Institute of Technology. He is a professor of organic chemistry and vice-dean of the Faculty of Sciences at the University of Tromsø. Dr. Svendsen is also a co-founder of Lytix Biopharma AS, a Norwegian pharmaceutical company focusing on cancer immunotherapy.

Njål Tage Gjerdalen holds a Medical Doctor degree from the University of Oslo and has cultivated a unique blend of expertise at the intersection of medicine and business. He brings six years of experience from national and international leadership roles at the pharmaceutical company Sanofi, where he managed two business units in Norway.

Pontus Lundberg brings experience in designing materials for biomedical applications both from industry and academia. His academic background includes a MSc in chemical engineering from Uppsala University and a PhD in polymer chemistry from KTH Royal Institute of Technology in Stockholm. Followingly, he spent 2 years as postdoctoral scholar at UC Santa Barbara. Most recently Pontus worked for Thermo Fisher Scientific for nearly 10 years in R&D both as a researcher and in management.